Properties	O
of	O
glucocorticoid	B-protein
receptors	I-protein
in	O
Epstein-Barr	B-cell_line
virus-transformed	I-cell_line
lymphocytes	I-cell_line
from	O
patients	O
with	O
familial	O
cortisol	O
resistance	O
.	O

In	O
a	O
previous	O
report	O
of	O
two	O
patients	O
with	O
familial	O
glucocorticoid	O
resistance	O
due	O
to	O
reduced	O
numbers	O
of	O
glucocorticoid	B-protein
receptors	I-protein
(	O
GR	B-protein
)	O
,	O
we	O
have	O
shown	O
decreased	O
numbers	O
of	O
GR	B-protein
in	O
peripheral	B-cell_type
mononuclear	I-cell_type
cells	I-cell_type
and	O
cultured	B-cell_line
fibroblasts	I-cell_line
but	O
normal	O
affinity	O
of	O
GR	B-protein
in	O
both	O
patients	O
.	O

In	O
this	O
study	O
,	O
peripheral	B-cell_type
lymphocytes	I-cell_type
from	O
these	O
patients	O
,	O
one	O
patient	O
's	O
son	O
and	O
daughter	O
,	O
and	O
normal	O
subjects	O
were	O
transformed	O
with	O
Epstein-Barr	O
virus	O
.	O

Reduced	O
numbers	O
and	O
normal	O
affinity	O
of	O
GR	B-protein
were	O
found	O
in	O
the	O
Epstein-Barr	B-cell_line
virus-transformed	I-cell_line
lymphocytes	I-cell_line
from	O
both	O
patients	O
while	O
the	O
son	O
and	O
daughter	O
had	O
normal	O
numbers	O
and	O
affinity	O
of	O
GR	B-protein
.	O

The	O
thermal	O
stability	O
of	O
GR	B-protein
and	O
thermal	O
activation	O
of	O
cytosolic	B-protein
receptors	I-protein
in	O
both	O
patients	O
were	O
found	O
to	O
be	O
normal	O
.	O

Although	O
the	O
percentages	O
of	O
nuclear	O
bound	O
GR	B-protein
were	O
similar	O
in	O
both	O
patients	O
and	O
normal	O
controls	O
,	O
the	O
absolute	O
amounts	O
of	O
nuclear	O
bound	O
GR	B-protein
of	O
the	O
patients	O
were	O
about	O
one-half	O
that	O
of	O
normal	O
controls	O
.	O

These	O
abnormal	O
properties	O
of	O
GR	B-protein
(	O
reduced	O
numbers	O
of	O
GR	B-protein
)	O
were	O
preserved	O
in	O
the	O
transformed	B-cell_line
cells	I-cell_line
from	O
the	O
patients	O
.	O

[	NULL
CANCER	NULL
RESEARCH	NULL
(	NULL
SUPPL	NULL
.	NULL
)	NULL

49	NULL
,	NULL
22145-22165	NULL
,	NULL
April	NULL
15	NULL
,	NULL
1989	NULL
]	NULL
Properties	NULL
of	NULL
Glucocorticoid	NULL
Receptors	NULL
in	NULL
Epstein-Barr	NULL
Virus-transformed	NULL
Lymphocytes	NULL
from	NULL
Patients	NULL
with	NULL
Familial	NULL
Cortisol	NULL
Resistance	NULL
'	NULL
Sayomi	NULL
lida	NULL
,	NULL
``	NULL
Masahiro	NULL
Gomi	NULL
,	NULL
Kaname	NULL
Moriwaki	NULL
,	NULL
Hiroshi	NULL
Fujii	NULL
,	NULL
Mamiko	NULL
Tsugawa	NULL
,	NULL
and	NULL
Seiichiro	NULL
Tarui	NULL
Second	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Osaka	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Fukushima	NULL
,	NULL
1-1-50	NULL
Fukushima	NULL
,	NULL
Osaka	NULL
553	NULL
,	NULL
Japan	NULL
Abstract	NULL
In	NULL
a	NULL
previous	NULL
report	NULL
of	NULL
two	NULL
patients	NULL
with	NULL
familial	NULL
glucocorticoid	NULL
resistance	NULL
due	NULL
to	NULL
reduced	NULL
numbers	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
(	NULL
GR	NULL
)	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
decreased	NULL
numbers	NULL
of	NULL
GR	NULL
in	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
and	NULL
cultured	NULL
fibroblasts	NULL
but	NULL
normal	NULL
affinity	NULL
of	NULL
GR	NULL
in	NULL
both	NULL
patients	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
peripheral	NULL
lymphocytes	NULL
from	NULL
these	NULL
patients	NULL
,	NULL
one	NULL
patient	NULL
's	NULL
son	NULL
and	NULL
daughter	NULL
,	NULL
and	NULL
normal	NULL
subjects	NULL
were	NULL
transformed	NULL
with	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Reduced	NULL
numbers	NULL
and	NULL
normal	NULL
affinity	NULL
of	NULL
GR	NULL
were	NULL
found	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus-transformed	NULL
lymphocytes	NULL
from	NULL
both	NULL
patients	NULL
while	NULL
the	NULL
son	NULL
and	NULL
daughter	NULL
had	NULL
normal	NULL
numbers	NULL
and	NULL
affinity	NULL
of	NULL
GR	NULL
.	NULL

The	NULL
thermal	NULL
stability	NULL
of	NULL
GR	NULL
and	NULL
thermal	NULL
activation	NULL
of	NULL
cytosolic	NULL
receptors	NULL
in	NULL
both	NULL
patients	NULL
were	NULL
found	NULL
to	NULL
be	NULL
normal	NULL
.	NULL

Aithough	NULL
the	NULL
percentages	NULL
of	NULL
nuclear	NULL
bound	NULL
GR	NULL
were	NULL
similar	NULL
in	NULL
both	NULL
patients	NULL
and	NULL
normal	NULL
controls	NULL
,	NULL
the	NULL
absolute	NULL
amounts	NULL
of	NULL
nuclear	NULL
bound	NULL
GR	NULL
of	NULL
the	NULL
patients	NULL
were	NULL
about	NULL
one-half	NULL
that	NULL
of	NULL
normal	NULL
controls	NULL
.	NULL

These	NULL
abnormal	NULL
properties	NULL
of	NULL
GR	NULL
(	NULL
reduced	NULL
numbers	NULL
of	NULL
GR	NULL
)	NULL
were	NULL
preserved	NULL
in	NULL
the	NULL
transformed	NULL
cells	NULL
from	NULL
the	NULL
patients	NULL
.	NULL

Introduction	NULL
We	NULL
have	NULL
previously	NULL
reported	NULL
two	NULL
patients	NULL
in	NULL
the	NULL
same	NULL
family	NULL
with	NULL
primary	NULL
cortisol	NULL
resistance	NULL
accompanied	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
numbers	NULL
of	NULL
GR	NULL
in	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

These	NULL
patients	NULL
,	NULL
patient	NULL
I	NULL
(	NULL
35-year-old	NULL
male	NULL
)	NULL
and	NULL
patient	NULL
II	NULL
(	NULL
mother	NULL
)	NULL
,	NULL
had	NULL
sustained	NULL
hypercortisolemia	NULL
,	NULL
but	NULL
they	NULL
presented	NULL
no	NULL
manifestation	NULL
of	NULL
Cushing	NULL
's	NULL
syndrome	NULL
.	NULL

Although	NULL
there	NULL
was	NULL
a	NULL
slight	NULL
elevation	NULL
of	NULL
plasma	NULL
deoxycorticosterone	NULL
levels	NULL
in	NULL
patient	NULL
I	NULL
and	NULL
corticosterone	NULL
in	NULL
patient	NULL
II	NULL
,	NULL
both	NULL
patients	NULL
exhibited	NULL
mild	NULL
hypertension	NULL
without	NULL
hypokalemia	NULL
.	NULL

Both	NULL
patients	NULL
were	NULL
partially	NULL
resistant	NULL
to	NULL
Dex	NULL
adrenal	NULL
suppression	NULL
.	NULL

Reduced	NULL
numbers	NULL
but	NULL
normal	NULL
affinity	NULL
of	NULL
GR	NULL
were	NULL
found	NULL
in	NULL
the	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
from	NULL
both	NULL
patients	NULL
and	NULL
in	NULL
the	NULL
cultured	NULL
skin	NULL
fibroblasts	NULL
from	NULL
patient	NULL
I	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Tritiated	NULL
thymidine	NULL
uptake	NULL
in	NULL
the	NULL
cultured	NULL
fibroblasts	NULL
from	NULL
patient	NULL
I	NULL
was	NULL
not	NULL
inhibited	NULL
to	NULL
the	NULL
extent	NULL
observed	NULL
with	NULL
fibroblasts	NULL
from	NULL
normal	NULL
individuals	NULL
,	NULL
indicating	NULL
a	NULL
resistance	NULL
of	NULL
the	NULL
patient	NULL
's	NULL
cells	NULL
to	NULL
Dex	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
aim	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
examine	NULL
the	NULL
properties	NULL
of	NULL
GR	NULL
after	NULL
transformation	NULL
by	NULL
EBV	NULL
in	NULL
lymphocytes	NULL
obtained	NULL
from	NULL
the	NULL
patients	NULL
and	NULL
other	NULL
family	NULL
members	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
[	NULL
PH	NULL
]	NULL
Dexamethasone	NULL
(	NULL
49	NULL
Ci/mmol	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Nuclear	NULL
(	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
;	NULL
Dex	NULL
,	NULL
dithiothreitol	NULL
,	NULL
and	NULL
EDTA	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
;	NULL
DNA-cellulose	NULL
was	NULL
from	NULL
Bio-Rad	NULL
(	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
and	NULL
FCS	NULL
was	NULL
from	NULL
Flow	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
(	NULL
Sydney	NULL
,	NULL
Australia	NULL
)	NULL
.	NULL

Transformation	NULL
of	NULL
Lymphocytes	NULL
with	NULL
EBV	NULL
.	NULL

Sterile	NULL
heparinized	NULL
blood	NULL
(	NULL
20	NULL
ml	NULL
)	NULL
was	NULL
collected	NULL
from	NULL
the	NULL
patients	NULL
,	NULL
patient	NULL
I	NULL
's	NULL
son	NULL
and	NULL
daughter	NULL
,	NULL
and	NULL
ten	NULL
normal	NULL
subjects	NULL
and	NULL
diluted	NULL
2-fold	NULL
with	NULL
saline	NULL
.	NULL

The	NULL
mononuclear	NULL
cell	NULL
fraction	NULL
was	NULL
separated	NULL
by	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

The	NULL
mononuclear	NULL
cell	NULL
suspensions	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
1	NULL
volume	NULL
of	NULL
10	NULL
%	NULL
sheep	NULL
RBC	NULL
suspensions	NULL
in	NULL
saline	NULL
'	NULL
Presented	NULL
at	NULL
the	NULL
Symposium	NULL
on	NULL
``	NULL
Glucocorticoid	NULL
Receptors	NULL
:	NULL
Evolution	NULL
,	NULL
Struc-ture	NULL
,	NULL
Function	NULL
and	NULL
Abnormalities	NULL
,	NULL
``	NULL
July	NULL
14	NULL
and	NULL
15	NULL
,	NULL
1988	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant-in-Aid	NULL
for	NULL
Scientific	NULL
Research	NULL
62480254	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
GR	NULL
,	NULL
glucocorticoid	NULL
receptors	NULL
;	NULL
Dex	NULL
,	NULL
dexametha-sone	NULL
;	NULL
EBV	NULL
,	NULL
Epstein-Barr	NULL
virus	NULL
;	NULL
FCS	NULL
,	NULL
fetal	NULL
calf	NULL
serum	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
ETG	NULL
buffer	NULL
,	NULL
1	NULL
mm	NULL
EDTA-20	NULL
mm	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.8-10	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
glycerol-2	NULL
mm	NULL
dithiothreitol	NULL
.	NULL

treated	NULL
with	NULL
neuraminidase	NULL
and	NULL
1	NULL
volume	NULL
of	NULL
FCS	NULL
and	NULL
then	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
2	NULL
h.	NULL
After	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
,	NULL
the	NULL
B-lymphocytes	NULL
were	NULL
separated	NULL
from	NULL
the	NULL
T-lymphocytes	NULL
which	NULL
formed	NULL
rosettes	NULL
.	NULL

The	NULL
B-lymphocytes	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
and	NULL
suspended	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
x	NULL
10°	NULL
cells/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
FCS	NULL
.	NULL

Aliquots	NULL
(	NULL
0.1	NULL
ml	NULL
)	NULL
of	NULL
B-lymphocyte	NULL
suspensions	NULL
were	NULL
mixed	NULL
with	NULL
0.1	NULL
ml	NULL
of	NULL
medium	NULL
containing	NULL
EBV	NULL
derived	NULL
from	NULL
B95-8	NULL
cells	NULL
(	NULL
2.5-5.0	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
in	NULL
24-well	NULL
plastic	NULL
culture	NULL
plates	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h	NULL
in	NULL
an	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
-95	NULL
%	NULL
humid	NULL
air	NULL
,	NULL
0.8	NULL
ml	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
FCS	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
.	NULL

Four	NULL
days	NULL
later	NULL
,	NULL
the	NULL
same	NULL
volume	NULL
of	NULL
fresh	NULL
medium	NULL
was	NULL
added	NULL
.	NULL

After	NULL
2	NULL
to	NULL
3	NULL
weeks	NULL
,	NULL
the	NULL
transformed	NULL
cells	NULL
began	NULL
to	NULL
proliferate	NULL
and	NULL
were	NULL
then	NULL
transferred	NULL
to	NULL
100-mm	NULL
tissue	NULL
culture	NULL
plates	NULL
and	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

GR	NULL
Assay	NULL
in	NULL
Whole	NULL
Cell	NULL
.	NULL

Whole	NULL
cell	NULL
binding	NULL
studies	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Transformed	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
serum	NULL
free	NULL
RPMI	NULL
1640	NULL
for	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
assay	NULL
and	NULL
were	NULL
judged	NULL
90	NULL
%	NULL
viable	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
assay	NULL
.	NULL

Aliquots	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
seven	NULL
concentrations	NULL
of	NULL
[	NULL
}	NULL
H	NULL
]	NULL
Dex	NULL
(	NULL
0.31-20	NULL
nm	NULL
)	NULL
for	NULL
6	NULL
h	NULL
at	NULL
24°C	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
Dex	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
3	NULL
ml	NULL
ice-cold	NULL
PBS	NULL
three	NULL
times	NULL
to	NULL
remove	NULL
free	NULL
steroid	NULL
and	NULL
centrifuged	NULL
at	NULL
400	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

After	NULL
the	NULL
final	NULL
wash	NULL
,	NULL
the	NULL
pellets	NULL
were	NULL
counted	NULL
for	NULL
radioactivity	NULL
.	NULL

Specific	NULL
binding	NULL
was	NULL
calculated	NULL
by	NULL
subtracting	NULL
nonspecific	NULL
binding	NULL
from	NULL
total	NULL
binding	NULL
and	NULL
these	NULL
data	NULL
were	NULL
analyzed	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Scatchard	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Nuclear	NULL
Binding	NULL
of	NULL
PHJDex	NULL
.	NULL

Transformed	NULL
lymphocytes	NULL
were	NULL
incubated	NULL
with	NULL
four	NULL
concentrations	NULL
of	NULL
[	NULL
'	NULL
H	NULL
]	NULL
Dex	NULL
(	NULL
0.31-2.5	NULL
nM	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
Dex	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
PBS	NULL
.	NULL

One-fifth	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
whole	NULL
cell	NULL
binding	NULL
and	NULL
the	NULL
remainder	NULL
to	NULL
determine	NULL
nuclear	NULL
binding	NULL
.	NULL

To	NULL
obtain	NULL
the	NULL
nuclear	NULL
fraction	NULL
,	NULL
cell	NULL
pellets	NULL
were	NULL
suspended	NULL
in	NULL
3	NULL
ml	NULL
ice-cold	NULL
hypotonic	NULL
buffer	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
containing	NULL
20	NULL
mM	NULL
N-tris	NULL
(	NULL
hydroxymethyl	NULL
)	NULL
methylglycine	NULL
,	NULL
2	NULL
mm	NULL
CaCl	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
MgCl	NULL
;	NULL
and	NULL
immediately	NULL
frozen	NULL
in	NULL
ethanol-dry	NULL
ice	NULL
(	NULL
5	NULL
)	NULL
.	NULL

After	NULL
room	NULL
temperature	NULL
thawing	NULL
,	NULL
the	NULL
lysed	NULL
cells	NULL
were	NULL
centrifuged	NULL
at	NULL
250	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
nuclear	NULL
pellets	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
hypotonic	NULL
buffer	NULL
and	NULL
counted	NULL
for	NULL
the	NULL
radioactivity	NULL
.	NULL

The	NULL
DNA	NULL
content	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
fluorometric	NULL
method	NULL
reported	NULL
by	NULL
Labarca	NULL
and	NULL
Paigen	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
Low-Speed	NULL
Cytosol	NULL
.	NULL

Transformed	NULL
lymphocytes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
room	NULL
temperature	NULL
PBS	NULL
.	NULL

Pellets	NULL
were	NULL
resus-pended	NULL
in	NULL
ice-cold	NULL
ETG	NULL
buffer	NULL
in	NULL
an	NULL
all-glass	NULL
Dounce	NULL
homogenizer	NULL
using	NULL
20	NULL
manual	NULL
strokes	NULL
.	NULL

These	NULL
homogenates	NULL
were	NULL
centrifuged	NULL
at	NULL
11,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
supernatants	NULL
represented	NULL
the	NULL
low-speed	NULL
cytosol	NULL
(	NULL
2	NULL
mg	NULL
protein/ml	NULL
cytosol	NULL
)	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Protein	NULL
content	NULL
was	NULL
measured	NULL
by	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

DNA-Cellulose	NULL
Chromatography	NULL
.	NULL

The	NULL
low-speed	NULL
cytosol	NULL
was	NULL
incubated	NULL
with	NULL
50	NULL
nm	NULL
[	NULL
°H	NULL
]	NULL
Dex	NULL
at	NULL
0°C	NULL
for	NULL
4	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
Dex	NULL
.	NULL

Dextran-coated	NULL
charcoal	NULL
[	NULL
final	NULL
concentration	NULL
,	NULL
charcoal	NULL
1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
,	NULL
dextran	NULL
0.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
]	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cytosol	NULL
and	NULL
centrifuged	NULL
to	NULL
remove	NULL
unbound	NULL
steroid	NULL
.	NULL

Activation	NULL
was	NULL
accomplished	NULL
by	NULL
incubating	NULL
the	NULL
cytosol	NULL
at	NULL
25°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
an	NULL
ice	NULL
bath	NULL
,	NULL
and	NULL
loaded	NULL
onto	NULL
a	NULL
1-ml	NULL
4°C	NULL
DNA-cellulose	NULL
column	NULL
that	NULL
had	NULL
been	NULL
equilibrated	NULL
with	NULL
ETG	NULL
buffer	NULL
.	NULL

After	NULL
15	NULL
min	NULL
incubation	NULL
,	NULL
the	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
six	NULL
column	NULL
volumes	NULL
of	NULL
ETG	NULL
buffer	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
sample	NULL
was	NULL
eluted	NULL
with	NULL
ETG	NULL
buffer	NULL
containing	NULL
stepwise	NULL
addition	NULL
of	NULL
KCI	NULL
(	NULL
0.05	NULL
,	NULL
0.10	NULL
,	NULL
0.15	NULL
,	NULL
0.20	NULL
,	NULL
0.25	NULL
,	NULL
and	NULL
0.30	NULL
M	NULL
)	NULL
.	NULL

Fractions	NULL
(	NULL
0.5	NULL
ml	NULL
)	NULL
were	NULL
collected	NULL
and	NULL
their	NULL
radioactivity	NULL
was	NULL
determined	NULL
.	NULL

Thermostability	NULL
of	NULL
GR	NULL
.	NULL

Transformed	NULL
lymphocytes	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
room	NULL
temperature	NULL
PBS	NULL
and	NULL
preincubated	NULL
in	NULL
RPMI	NULL
1640	NULL
at	NULL
30°C	NULL
,	NULL
37°C	NULL
,	NULL
and	NULL
42°C	NULL
for	NULL
60	NULL
min	NULL
;	NULL
then	NULL
50	NULL
nm	NULL
[	NULL
°H	NULL
]	NULL
Dex	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
100-fold	NULL
excess	NULL
unlabeled	NULL
Dex	NULL
was	NULL
added	NULL
for	NULL
60	NULL
min	NULL
.	NULL

After	NULL
this	NULL
incubation	NULL
at	NULL
the	NULL
indicated	NULL
temperatures	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
2214s	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1989	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GR	NULL
OF	NULL
FAMILIAL	NULL
CORTISOL	NULL
RESISTANCE	NULL
times	NULL
with	NULL
PBS	NULL
and	NULL
centrifuged	NULL
,	NULL
and	NULL
the	NULL
pellets	NULL
were	NULL
counted	NULL
for	NULL
radioactivity	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Results	NULL
Dex	NULL
Binding	NULL
in	NULL
Whole	NULL
Cells	NULL
.	NULL

The	NULL
binding	NULL
capacity	NULL
of	NULL
GR	NULL
in	NULL
the	NULL
transformed	NULL
cells	NULL
from	NULL
patients	NULL
I	NULL
and	NULL
II	NULL
were	NULL
about	NULL
one-half	NULL
those	NULL
of	NULL
normal	NULL
subjects	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
;	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
apparent	NULL
dissociation	NULL
constant	NULL
(	NULL
K	NULL
,	NULL
)	NULL
was	NULL
normal	NULL
for	NULL
both	NULL
patients	NULL
.	NULL

The	NULL
binding	NULL
capacity	NULL
and	NULL
K	NULL
,	NULL
of	NULL
GR	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
son	NULL
and	NULL
daughter	NULL
of	NULL
patient	NULL
I	NULL
were	NULL
normal	NULL
.	NULL

|	NULL
>	NULL
6	NULL
0	NULL
Patient	NULL
I	NULL
a	NULL
Patient	NULL
I	NULL
®	NULL
Son	NULL
A	NULL
-	NULL
Daughter	NULL
[	NULL
*H	NULL
}	NULL
-DEXAMETHASONE	NULL
BOUND	NULL
(	NULL
fmoles/10®	NULL
cells	NULL
)	NULL
5	NULL
3	NULL
.	NULL

=	NULL
10	NULL
15	NULL
20	NULL
[	NULL
*H	NULL
}	NULL
-DEXAMETHASONE	NULL
(	NULL
nM	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Specific	NULL
dexamethasone	NULL
binding	NULL
to	NULL
EBV-transformed	NULL
lymphocytes	NULL
.	NULL

Cells	NULL
obtained	NULL
from	NULL
patient	NULL
1	NULL
,	NULL
patient	NULL
II	NULL
,	NULL
patient	NULL
I	NULL
's	NULL
son	NULL
and	NULL
daughter	NULL
,	NULL
and	NULL
then	NULL
normal	NULL
subjects	NULL
were	NULL
incubated	NULL
concurrently	NULL
for	NULL
6	NULL
h	NULL
at	NULL
24°C	NULL
.	NULL

Shaded	NULL
area	NULL
,	NULL
range	NULL
of	NULL
the	NULL
ten	NULL
normal	NULL
subjects	NULL
.	NULL

Values	NULL
were	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
(	NULL
bars	NULL
)	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

o	NULL
A	NULL
-O-	NULL
Patient	NULL
I	NULL
--	NULL
&	NULL
--	NULL
Patient	NULL
I	NULL
-	NULL
#	NULL
-	NULL
Son	NULL
--	NULL
«	NULL
--	NULL
Daughter	NULL
[	NULL
°H	NULL
}	NULL
-DEXAMETHASONE	NULL
BOUND	NULL
(	NULL
fmoles/10®	NULL
cells	NULL
)	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Scatchard	NULL
analysis	NULL
of	NULL
dexamethasone	NULL
binding	NULL
to	NULL
GR	NULL
of	NULL
EBV-transformed	NULL
lymphocytes	NULL
in	NULL
patient	NULL
I	NULL
,	NULL
patient	NULL
II	NULL
,	NULL
patient	NULL
I	NULL
's	NULL
son	NULL
and	NULL
daughter	NULL
,	NULL
and	NULL
ten	NULL
normal	NULL
subjects	NULL
(	NULL
shaded	NULL
area	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
receptors	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
intercept	NULL
of	NULL
the	NULL
x-axis	NULL
,	NULL
while	NULL
apparent	NULL
affinity	NULL
is	NULL
demonstrated	NULL
by	NULL
the	NULL
slope	NULL
of	NULL
the	NULL
line	NULL
(	NULL
slope	NULL
=	NULL
-1/K	NULL
,	NULL
)	NULL
.	NULL

Table	NULL
1	NULL
GR	NULL
in	NULL
EBV-transformed	NULL
lymphocytes	NULL
Binding	NULL
capacity	NULL
Ka	NULL
(	NULL
fmol/10®	NULL
cells	NULL
)	NULL
(	NULL
nm	NULL
)	NULL
Patient	NULL
I	NULL
24.9	NULL
+	NULL
1.6	NULL
``	NULL
1.87	NULL
+	NULL
0.15°	NULL
Patient	NULL
II	NULL
27.8	NULL
£	NULL
4.3	NULL
``	NULL
1.89	NULL
+	NULL
0.12	NULL
``	NULL
Son	NULL
55.6	NULL
£	NULL
4.0	NULL
``	NULL
1.74	NULL
+	NULL
0.04	NULL
``	NULL
Daughter	NULL
49.2	NULL
+	NULL
3.2	NULL
``	NULL
1.43	NULL
+	NULL
0.10	NULL
``	NULL
Normal	NULL
subjects	NULL
53.2	NULL
£	NULL
3.8°	NULL
1.60	NULL
+	NULL
0.22	NULL
``	NULL
Mean	NULL
+	NULL
SD	NULL
of	NULL
5	NULL
experiments	NULL
.	NULL

*	NULL
Mean	NULL
+	NULL
SD	NULL
of	NULL
3	NULL
experiments	NULL
.	NULL

©	NULL
Mean	NULL
+	NULL
SD	NULL
,	NULL
a	NULL
=	NULL
10	NULL
.	NULL

Table	NULL
2	NULL
Nuclear	NULL
retention	NULL
of	NULL
GR-	NULL
[	NULL
PH	NULL
]	NULL
Dex	NULL
complexes	NULL
The	NULL
percentages	NULL
of	NULL
nuclear	NULL
receptors	NULL
were	NULL
calculated	NULL
as	NULL
counts	NULL
for	NULL
radioactivity	NULL
of	NULL
nuclear	NULL
fraction	NULL
divided	NULL
by	NULL
counts	NULL
for	NULL
radioactivity	NULL
of	NULL
whole	NULL
cell	NULL
binding	NULL
,	NULL
then	NULL
multiplied	NULL
by	NULL
100	NULL
.	NULL

Concentration	NULL
%	NULL
of	NULL
nuclear	NULL
receptor	NULL
of	NULL
added	NULL
(	NULL
nM	NULL
)	NULL
Patient	NULL
I	NULL
Patient	NULL
II	NULL
Control	NULL
0.31	NULL
15.2	NULL
,	NULL
16.7	NULL
17.3	NULL
,	NULL
19.9	NULL
17.9	NULL
%	NULL
2.1°	NULL
0.63	NULL
17.3	NULL
,	NULL
16.3	NULL
21.2	NULL
,	NULL
22.3	NULL
18.0	NULL
+	NULL
2.4°	NULL
1.25	NULL
17.8	NULL
,	NULL
19.6	NULL
20.4	NULL
,	NULL
17.1	NULL
19.6	NULL
+	NULL
1.6	NULL
``	NULL
2.50	NULL
17.3	NULL
,	NULL
14.1	NULL
20.1	NULL
,	NULL
15.5	NULL
18.7	NULL
£	NULL
2.7	NULL
``	NULL
``	NULL
Mean	NULL
+	NULL
SD	NULL
,	NULL
n	NULL
=	NULL
8	NULL
.	NULL

Table	NULL
3	NULL
Absolute	NULL
amounts	NULL
of	NULL
GR-	NULL
[	NULL
®HJDex	NULL
complexes	NULL
bound	NULL
to	NULL
nuclei	NULL
Absolute	NULL
amounts	NULL
of	NULL
GR-	NULL
[	NULL
°	NULL
'	NULL
H	NULL
]	NULL
}	NULL
Dex	NULL
complexes	NULL
bound	NULL
to	NULL
nuclei	NULL
were	NULL
calculated	NULL
when	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
2.5	NULL
nm	NULL
(	NULL
°H	NULL
}	NULL
Dex	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

GR	NULL
complexes	NULL
(	NULL
fmol/10	NULL
ug	NULL
DNA	NULL
)	NULL
Patient	NULL
I	NULL
2.8	NULL
,	NULL
2.4	NULL
Patient	NULL
II	NULL
3.5	NULL
,	NULL
3.0	NULL
Control	NULL
5.8	NULL
£	NULL
0.7	NULL
``	NULL
``	NULL
Mean	NULL
+	NULL
SD	NULL
,	NULL
n	NULL
=	NULL
8	NULL
.	NULL

KCI	NULL
(	NULL
M	NULL
)	NULL
o	NULL
Fq	NULL
9.10	NULL
o.18	NULL
|	NULL
0	NULL
0.10	NULL
0.15	NULL
0.20~	NULL
3	NULL
g	NULL
2,000	NULL
s	NULL
1,000	NULL
[	NULL
°H	NULL
}	NULL
-DEXAMETHASONE	NULL
DPM/FRACTION	NULL
hd	NULL
1	NULL
15	NULL
20	NULL
25	NULL
30	NULL
35	NULL
40	NULL
FRACTION	NULL
NUMBER	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

DNA-cellulose	NULL
chromatography	NULL
GR-	NULL
[	NULL
°'HJDEX	NULL
complexes	NULL
obtained	NULL
from	NULL
EBV-transformed	NULL
lymphocytes	NULL
of	NULL
patient	NULL
I	NULL
,	NULL
patient	NULL
II	NULL
,	NULL
and	NULL
five	NULL
normal	NULL
subjects	NULL
after	NULL
heat	NULL
activation	NULL
.	NULL

Low-speed	NULL
cytosol	NULL
(	NULL
1.0	NULL
ml	NULL
;	NULL
2	NULL
mg	NULL
protein/ml	NULL
)	NULL
was	NULL
preincubated	NULL
with	NULL
50	NULL
nm	NULL
[	NULL
°H	NULL
]	NULL
Dex	NULL
for	NULL
4	NULL
h	NULL
at	NULL
0°C	NULL
.	NULL

Activation	NULL
of	NULL
GR-	NULL
[	NULL
'	NULL
H	NULL
]	NULL
Dex	NULL
complexes	NULL
was	NULL
produced	NULL
by	NULL
a	NULL
30-min	NULL
incubation	NULL
at	NULL
25°C	NULL
.	NULL

Table	NULL
4	NULL
GR-/*H	NULL
]	NULL
Dex	NULL
complexes	NULL
bound	NULL
to	NULL
DNA-cellulose	NULL
column	NULL
The	NULL
percentages	NULL
of	NULL
retained	NULL
GR	NULL
complexes	NULL
were	NULL
calculated	NULL
as	NULL
counts	NULL
for	NULL
radioactivity	NULL
of	NULL
retained	NULL
fractions	NULL
divided	NULL
by	NULL
counts	NULL
for	NULL
radioactivity	NULL
of	NULL
retained	NULL
plus	NULL
flowthrough	NULL
fractions	NULL
then	NULL
multiplied	NULL
by	NULL
100	NULL
.	NULL

Retained	NULL
GR	NULL
complexes	NULL
(	NULL
%	NULL
)	NULL
Patient	NULL
I	NULL
35.4	NULL
+	NULL
4.0°	NULL
Patient	NULL
II	NULL
37.1	NULL
+	NULL
1.8	NULL
``	NULL
Control	NULL
40.2	NULL
+	NULL
2.9	NULL
``	NULL
``	NULL
Mean	NULL
+	NULL
SD	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

*	NULL
Mean	NULL
+	NULL
SD	NULL
,	NULL
n	NULL
=	NULL
5	NULL
.	NULL

Nuclear	NULL
Binding	NULL
.	NULL

Table	NULL
2	NULL
shows	NULL
the	NULL
nuclear	NULL
retention	NULL
of	NULL
GR-	NULL
[	NULL
PH	NULL
]	NULL
}	NULL
Dex	NULL
complexes	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
nuclear	NULL
bound	NULL
receptors	NULL
of	NULL
both	NULL
patients	NULL
were	NULL
approximately	NULL
those	NULL
of	NULL
normal	NULL
subjects	NULL
.	NULL

Absolute	NULL
amounts	NULL
of	NULL
nuclear	NULL
receptors	NULL
per	NULL
10	NULL
ug	NULL
of	NULL
DNA	NULL
of	NULL
both	NULL
patients	NULL
were	NULL
reduced	NULL
to	NULL
about	NULL
one-half	NULL
those	NULL
of	NULL
normal	NULL
subjects	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

DNA-Cellulose	NULL
Chromatography	NULL
.	NULL

GR-	NULL
{	NULL
°H	NULL
]	NULL
Dex	NULL
complexes	NULL
eluted	NULL
in	NULL
two	NULL
peaks	NULL
with	NULL
ETG	NULL
buffer	NULL
containing	NULL
0.1	NULL
and	NULL
0.15	NULL
M	NULL
KC	NULL
]	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
elution	NULL
pattern	NULL
in	NULL
both	NULL
patients	NULL
was	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
normal	NULL
subjects	NULL
.	NULL

Table	NULL
4	NULL
summarizes	NULL
the	NULL
ratio	NULL
of	NULL
complexes	NULL
retained	NULL
on	NULL
the	NULL
DNA-cellulose	NULL
column	NULL
2215s	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1989	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

GR	NULL
OF	NULL
FAMILIAL	NULL
CORTISOL	NULL
RESISTANCE	NULL
HRJ	NULL
Cove	NULL
!	NULL

150	NULL
KZ	NULL
Patent	NULL
1	NULL
g	NULL
[	NULL
TT	NULL
]	NULL
Patient	NULL
1	NULL
2	NULL
$	NULL
3	NULL
$	NULL
2	NULL
10	NULL
E	NULL
$	NULL
f	NULL
z	NULL
.	NULL

3	NULL
£	NULL
T	NULL
``	NULL
so	NULL
#	NULL
I	NULL
T__	NULL
Redzc	NULL
1	NULL
___	NULL
|	NULL
___deX	NULL
1	NULL
...	NULL
azc	NULL
INCUBATION	NULL
TEMPERATURE	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Specific	NULL
binding	NULL
of	NULL
in	NULL
EBV-transformed	NULL
lymphocytes	NULL
from	NULL
patients	NULL
and	NULL
normal	NULL
subjects	NULL
at	NULL
various	NULL
incubation	NULL
temperatures	NULL
.	NULL

The	NULL
values	NULL
were	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SD	NULL
(	NULL
bars	NULL
)	NULL
of	NULL
three	NULL
experiments	NULL
in	NULL
both	NULL
patients	NULL
and	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
two	NULL
determinations	NULL
in	NULL
four	NULL
normal	NULL
subjects	NULL
.	NULL

versus	NULL
retained	NULL
plus	NULL
flowthrough	NULL
GR-	NULL
[	NULL
}	NULL
H	NULL
]	NULL
Dex	NULL
complexes	NULL
in	NULL
each	NULL
subjects	NULL
.	NULL

No	NULL
significant	NULL
difference	NULL
was	NULL
found	NULL
in	NULL
the	NULL
DNA-cellulose	NULL
binding	NULL
of	NULL
the	NULL
activated	NULL
GR	NULL
from	NULL
both	NULL
patients	NULL
as	NULL
compared	NULL
to	NULL
those	NULL
from	NULL
normal	NULL
subjects	NULL
.	NULL

Thermostability	NULL
of	NULL
GR	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
shows	NULL
the	NULL
specific	NULL
binding	NULL
capacity	NULL
of	NULL
GR	NULL
in	NULL
transformed	NULL
lymphocytes	NULL
at	NULL
various	NULL
incubation	NULL
temperatures	NULL
(	NULL
30°C	NULL
,	NULL
37°C	NULL
,	NULL
and	NULL
42°C	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
capacity	NULL
of	NULL
GR	NULL
in	NULL
cells	NULL
from	NULL
normal	NULL
subjects	NULL
was	NULL
decreased	NULL
with	NULL
elevated	NULL
temperature	NULL
.	NULL

At	NULL
any	NULL
temperature	NULL
,	NULL
the	NULL
binding	NULL
capacity	NULL
of	NULL
GR	NULL
in	NULL
cells	NULL
from	NULL
both	NULL
patients	NULL
was	NULL
about	NULL
one-half	NULL
those	NULL
of	NULL
normal	NULL
subjects	NULL
.	NULL

Discussion	NULL
The	NULL
binding	NULL
capacity	NULL
of	NULL
GR	NULL
in	NULL
EBV-transformed	NULL
lymphocytes	NULL
from	NULL
normal	NULL
subjects	NULL
was	NULL
increased	NULL
7-fold	NULL
over	NULL
that	NULL
of	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
binding	NULL
affinity	NULL
of	NULL
GR	NULL
in	NULL
transformed	NULL
lymphocytes	NULL
from	NULL
normal	NULL
subjects	NULL
remained	NULL
the	NULL
same	NULL
as	NULL
that	NULL
of	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
correspond	NULL
to	NULL
those	NULL
of	NULL
Tomita	NULL
et	NULL
al	NULL
.	NULL

(	NULL
9	NULL
)	NULL
who	NULL
reported	NULL
that	NULL
viral	NULL
transformation	NULL
of	NULL
peripheral	NULL
lymphocytes	NULL
was	NULL
associated	NULL
with	NULL
increased	NULL
numbers	NULL
of	NULL
GR	NULL
whereas	NULL
other	NULL
qualitative	NULL
characteristics	NULL
of	NULL
the	NULL
receptor	NULL
remained	NULL
similar	NULL
.	NULL

The	NULL
binding	NULL
capacity	NULL
of	NULL
GR	NULL
in	NULL
transformed	NULL
cells	NULL
of	NULL
patients	NULL
I	NULL
and	NULL
II	NULL
was	NULL
also	NULL
increased	NULL
6-	NULL
to	NULL
7-fold	NULL
that	NULL
of	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
,	NULL
while	NULL
the	NULL
binding	NULL
affinity	NULL
of	NULL
GR	NULL
was	NULL
the	NULL
same	NULL
as	NULL
that	NULL
of	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
number	NULL
of	NULL
GR	NULL
in	NULL
these	NULL
patients	NULL
'	NULL
cells	NULL
was	NULL
decreased	NULL
to	NULL
about	NULL
one-half	NULL
of	NULL
those	NULL
from	NULL
normal	NULL
subjects	NULL
.	NULL

The	NULL
affinity	NULL
of	NULL
GR	NULL
in	NULL
cells	NULL
from	NULL
both	NULL
patients	NULL
was	NULL
normal	NULL
.	NULL

These	NULL
results	NULL
correspond	NULL
to	NULL
data	NULL
obtained	NULL
in	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
son	NULL
and	NULL
daughter	NULL
of	NULL
patient	NULL
I	NULL
,	NULL
the	NULL
binding	NULL
capacity	NULL
and	NULL
the	NULL
affinity	NULL
of	NULL
GR	NULL
were	NULL
both	NULL
normal	NULL
.	NULL

Godlowski	NULL
and	NULL
Michaels	NULL
(	NULL
10	NULL
)	NULL
demonstrated	NULL
that	NULL
both	NULL
the	NULL
binding	NULL
capacity	NULL
and	NULL
affinity	NULL
of	NULL
GR	NULL
were	NULL
altered	NULL
at	NULL
the	NULL
cell	NULL
cycles	NULL
using	NULL
synchronized	NULL
HeLa	NULL
cell	NULL
cultures	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
by	NULL
Crabtree	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
that	NULL
a	NULL
2-	NULL
to	NULL
3-fold	NULL
increase	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
sites	NULL
per	NULL
cell	NULL
in	NULL
cells	NULL
in	NULL
S	NULL
and	NULL
post-S	NULL
phase	NULL
was	NULL
observed	NULL
compared	NULL
to	NULL
those	NULL
in	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
and	NULL
G	NULL
;	NULL
phase	NULL
using	NULL
both	NULL
nonstimulated	NULL
rat	NULL
lymph	NULL
node	NULL
cell	NULL
suspensions	NULL
and	NULL
concanavalin	NULL
A-stimulated	NULL
human	NULL
peripheral	NULL
lymphocytes	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
transformed	NULL
lymphocytes	NULL
were	NULL
preincubated	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
to	NULL
synchronize	NULL
cell	NULL
cycles	NULL
to	NULL
the	NULL
G	NULL
phase	NULL
for	NULL
24	NULL
h	NULL
prior	NULL
to	NULL
the	NULL
binding	NULL
assay	NULL
.	NULL

Tomita	NULL
et	NULL
al	NULL
.	NULL

(	NULL
12	NULL
)	NULL
reported	NULL
reduced	NULL
numbers	NULL
and	NULL
affinity	NULL
of	NULL
GR	NULL
in	NULL
transformed	NULL
lymphocytes	NULL
from	NULL
their	NULL
patients	NULL
with	NULL
familial	NULL
cortisol	NULL
resistance	NULL
,	NULL
whose	NULL
GR	NULL
abnormalities	NULL
included	NULL
reduced	NULL
GR	NULL
affinity	NULL
(	NULL
13	NULL
)	NULL
.	NULL

They	NULL
speculated	NULL
that	NULL
induction	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
GR	NULL
by	NULL
EBV	NULL
transformation	NULL
was	NULL
also	NULL
impaired	NULL
in	NULL
patients	NULL
'	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
the	NULL
numbers	NULL
of	NULL
GR	NULL
in	NULL
transformed	NULL
cells	NULL
of	NULL
both	NULL
patients	NULL
were	NULL
reduced	NULL
to	NULL
one-half	NULL
of	NULL
those	NULL
in	NULL
transformed	NULL
cells	NULL
of	NULL
normal	NULL
subjects	NULL
.	NULL

Thus	NULL
,	NULL
induction	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
GR	NULL
in	NULL
the	NULL
patients	NULL
'	NULL
lymphocytes	NULL
by	NULL
transformation	NULL
appeared	NULL
to	NULL
take	NULL
place	NULL
to	NULL
the	NULL
same	NULL
degree	NULL
as	NULL
in	NULL
transformed	NULL
cells	NULL
of	NULL
normal	NULL
subjects	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
GR-	NULL
[	NULL
°H	NULL
]	NULL
Dex	NULL
complexes	NULL
bound	NULL
to	NULL
nuclei	NULL
in	NULL
both	NULL
patients	NULL
were	NULL
the	NULL
same	NULL
as	NULL
normal	NULL
ones	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
transfer	NULL
of	NULL
GR-	NULL
[	NULL
}	NULL
H	NULL
]	NULL
Dex	NULL
complexes	NULL
to	NULL
nuclei	NULL
in	NULL
both	NULL
patients	NULL
was	NULL
normal	NULL
.	NULL

Since	NULL
the	NULL
elution	NULL
pattern	NULL
in	NULL
DNA-cellulose	NULL
chromatography	NULL
of	NULL
GR-	NULL
[	NULL
°H	NULL
}	NULL
Dex	NULL
complexes	NULL
in	NULL
both	NULL
patients	NULL
was	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
normal	NULL
subjects	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
GR	NULL
in	NULL
both	NULL
patients	NULL
'	NULL
cells	NULL
to	NULL
DNA	NULL
was	NULL
normal	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
GR-	NULL
[	NULL
'	NULL
H	NULL
]	NULL
Dex	NULL
complexes	NULL
retained	NULL
to	NULL
the	NULL
DNA	NULL
column	NULL
against	NULL
the	NULL
retained	NULL
plus	NULL
flowthrough	NULL
in	NULL
both	NULL
patients	NULL
was	NULL
also	NULL
normal	NULL
.	NULL

Therefore	NULL
,	NULL
heat	NULL
activation	NULL
of	NULL
GR	NULL
complexes	NULL
in	NULL
both	NULL
patients	NULL
appears	NULL
to	NULL
be	NULL
accomplished	NULL
normally	NULL
.	NULL

Although	NULL
elevated	NULL
temperature	NULL
caused	NULL
decreases	NULL
in	NULL
[	NULL
°H	NULL
]	NULL
Dex	NULL
binding	NULL
to	NULL
cells	NULL
in	NULL
both	NULL
normal	NULL
subjects	NULL
and	NULL
patients	NULL
,	NULL
at	NULL
each	NULL
incubation	NULL
temperature	NULL
,	NULL
[	NULL
PH	NULL
]	NULL
Dex	NULL
binding	NULL
to	NULL
cells	NULL
in	NULL
patients	NULL
was	NULL
reduced	NULL
to	NULL
about	NULL
one-half	NULL
that	NULL
in	NULL
normal	NULL
ones	NULL
.	NULL

Therefore	NULL
,	NULL
thermolability	NULL
of	NULL
GR	NULL
in	NULL
both	NULL
patients	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
normal	NULL
.	NULL

Decreased	NULL
numbers	NULL
with	NULL
normal	NULL
affinity	NULL
of	NULL
GR	NULL
in	NULL
transformed	NULL
lymphocytes	NULL
from	NULL
our	NULL
patients	NULL
with	NULL
familial	NULL
cortisol	NULL
resistance	NULL
were	NULL
demonstrated	NULL
as	NULL
shown	NULL
in	NULL
peripheral	NULL
mononuclear	NULL
cells	NULL
.	NULL

No	NULL
abnormalities	NULL
of	NULL
the	NULL
patients	NULL
'	NULL
GR	NULL
in	NULL
nuclear	NULL
binding	NULL
,	NULL
DNA	NULL
binding	NULL
,	NULL
and	NULL
thermolability	NULL
were	NULL
found	NULL
.	NULL

Since	NULL
the	NULL
abnormal	NULL
properties	NULL
of	NULL
GR	NULL
in	NULL
these	NULL
patients	NULL
also	NULL
remained	NULL
in	NULL
transformed	NULL
lymphocytes	NULL
,	NULL
these	NULL
cells	NULL
appear	NULL
to	NULL
be	NULL
a	NULL
useful	NULL
source	NULL
for	NULL
analyzing	NULL
gene	NULL
abnormalities	NULL
.	NULL

Acknowledgments	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
M.	NULL
Hashimoto	NULL
,	NULL
Nishinomiya	NULL
Prefecture	NULL
Hospital	NULL
,	NULL
for	NULL
the	NULL
supply	NULL
of	NULL
EBV	NULL
and	NULL
to	NULL
Dr.	NULL
T.	NULL
Tamaki	NULL
in	NULL
our	NULL
department	NULL
for	NULL
advice	NULL
concerning	NULL
B-lymphocyte	NULL
separation	NULL
.	NULL

References	NULL
1.	NULL
lida	NULL
,	NULL
S.	NULL
,	NULL
Gomi	NULL
,	NULL
M.	NULL
,	NULL
Moriwaki	NULL
,	NULL
K.	NULL
,	NULL
Itoh	NULL
,	NULL
Y.	NULL
,	NULL
Hirobe	NULL
,	NULL
K.	NULL
,	NULL
Matsuzawa	NULL
,	NULL
Y.	NULL
,	NULL
Katagiri	NULL
,	NULL
S.	NULL
,	NULL
Yonezawa	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tarui	NULL
,	NULL
S.	NULL
Primary	NULL
cortisol	NULL
resistance	NULL
accompanied	NULL
by	NULL
a	NULL
reduction	NULL
in	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
two	NULL
members	NULL
of	NULL
the	NULL
same	NULL
family	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

,	NULL
60	NULL
:	NULL
967-971	NULL
,	NULL
1985	NULL
.	NULL

2	NULL
.	NULL

Gomi	NULL
,	NULL
M.	NULL
,	NULL
lida	NULL
,	NULL
S.	NULL
,	NULL
Tsugawa	NULL
,	NULL
M.	NULL
,	NULL
Itoh	NULL
,	NULL
Y.	NULL
,	NULL
Moriwaki	NULL
,	NULL
K.	NULL
,	NULL
Yamashita	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Tarui	NULL
,	NULL
S.	NULL
Decreased	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
cultured	NULL
skin	NULL
fibroblasts	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
primary	NULL
cortisol	NULL
resistance	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
374	NULL
:	NULL
1194	NULL
,	NULL
1986	NULL
.	NULL

3	NULL
.	NULL

Gomi	NULL
,	NULL
M.	NULL
,	NULL
Iida	NULL
,	NULL
S.	NULL
,	NULL
Tsugawa	NULL
,	NULL
M.	NULL
,	NULL
Itoh	NULL
,	NULL
Y.	NULL
,	NULL
Moriwaki	NULL
,	NULL
K.	NULL
,	NULL
Fujii	NULL
,	NULL
H.	NULL
,	NULL
Yamashita	NULL
,	NULL
S.	NULL
,	NULL
Tamaki	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Tarui	NULL
,	NULL
S.	NULL
In	NULL
vitro	NULL
studies	NULL
of	NULL
skin	NULL
fibroblasts	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
a	NULL
new	NULL
type	NULL
of	NULL
primary	NULL
cortisol	NULL
resistance	NULL
:	NULL
glucocorticoid	NULL
receptor	NULL
status	NULL
and	NULL
glucocorticoid	NULL
effect	NULL
on	NULL
DNA	NULL
synthesis	NULL
.	NULL

Horm	NULL
.	NULL

Metab	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
19	NULL
:	NULL
328-330	NULL
,	NULL
1987	NULL
.	NULL

4	NULL
.	NULL

Scatchard	NULL
,	NULL
G.	NULL
The	NULL
attraction	NULL
of	NULL
proteins	NULL
for	NULL
small	NULL
molecules	NULL
and	NULL
ions	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
51	NULL
:	NULL
660-672	NULL
,	NULL
1949	NULL
,	NULL
5	NULL
.	NULL

Yamamoto	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Gehring	NULL
,	NULL
U.	NULL
,	NULL
Stampfer	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Sibley	NULL
,	NULL
C.	NULL
H.	NULL
Genetic	NULL
aggzoaches	NULL
to	NULL
steroid	NULL
hormone	NULL
action	NULL
.	NULL

Recent	NULL
Prog	NULL
.	NULL

Horm	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
32	NULL
:	NULL
3-32	NULL
,	NULL
1976	NULL
.	NULL

6	NULL
.	NULL

Labarca	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Paigen	NULL
,	NULL
K.	NULL
A	NULL
simple	NULL
,	NULL
rapid	NULL
and	NULL
sensitive	NULL
DNA	NULL
assay	NULL
procedure	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
102	NULL
:	NULL
344-352	NULL
,	NULL
1980	NULL
.	NULL

7	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Bodwell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jeffries	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Munck	NULL
,	NULL
A	NULL
.	NULL

Characterization	NULL
of	NULL
nonactivated	NULL
and	NULL
activated	NULL
glucocorticoid	NULL
receptor	NULL
complexes	NULL
from	NULL
intact	NULL
rat	NULL
thymus	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
258	NULL
:	NULL
6477-6485	NULL
,	NULL
1983	NULL
.	NULL

8	NULL
.	NULL

Bronnegird	NULL
,	NULL
M.	NULL
,	NULL
Werner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Gustafsson	NULL
,	NULL
J.-A	NULL
.	NULL

Primary	NULL
cortisol	NULL
resistance	NULL
associated	NULL
with	NULL
a	NULL
thermolabile	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
fatigue	NULL
as	NULL
the	NULL
only	NULL
symptom	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
78	NULL
:	NULL
1270-1278	NULL
,	NULL
1986	NULL
.	NULL

9	NULL
.	NULL

Tomita	NULL
,	NULL
M.	NULL
,	NULL
Chrousos	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Brandon	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Ben-Or	NULL
,	NULL
S.	NULL
,	NULL
Foster	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
DeVough	NULL
,	NULL
L.	NULL
,	NULL
Taylor	NULL
,	NULL
S.	NULL
,	NULL
Loriaux	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Lipsett	NULL
,	NULL
M.	NULL
B.	NULL
Glucocorticoid	NULL
receptors	NULL
in	NULL
Epstein-Barr	NULL
virus-transformed	NULL
human	NULL
lymphocytes	NULL
.	NULL

Horm	NULL
.	NULL

Metab	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
17	NULL
:	NULL
674-678	NULL
,	NULL
1985	NULL
.	NULL

10	NULL
.	NULL

Gidlowski	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Michaels	NULL
,	NULL
G.	NULL
A.	NULL
Alteration	NULL
in	NULL
glucocorticoid	NULL
binding	NULL
ate5	NULL
nluglgger	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
266	NULL
;	NULL
643-	NULL
,	NULL
.	NULL

11	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Munck	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
K.	NULL
A.	NULL
Glucocorticoids	NULL
and	NULL
lymphocytes	NULL
II	NULL
.	NULL

Cell	NULL
cycle-dependent	NULL
changes	NULL
in	NULL
glucocorticoid	NULL
receptor	NULL
content	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
725	NULL
:	NULL
13-17	NULL
,	NULL
1980	NULL
.	NULL

12	NULL
.	NULL

Tomita	NULL
,	NULL
M.	NULL
,	NULL
Brandon	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Chrousos	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Vingerhoeds	NULL
,	NULL
A.	NULL
C.	NULL
M.	NULL
,	NULL
Foster	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Fowler	NULL
,	NULL
D.	NULL
,	NULL
Loriaux	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Lipsett	NULL
,	NULL
M.	NULL
B.	NULL
Glucocorticoid	NULL
receptors	NULL
in	NULL
Epstein-Barr	NULL
virus-transformed	NULL
lymphocytes	NULL
from	NULL
patients	NULL
with	NULL
glucocorticoid	NULL
resistance	NULL
and	NULL
new	NULL
world	NULL
primate	NULL
species	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

,	NULL
62	NULL
:	NULL
1145-1154	NULL
,	NULL
1986	NULL
.	NULL

13	NULL
.	NULL

Chrousos	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Vingerhoeds	NULL
,	NULL
A.	NULL
,	NULL
Brandon	NULL
,	NULL
D.	NULL
,	NULL
Charles	NULL
,	NULL
E.	NULL
,	NULL
Pugeat	NULL
,	NULL
M.	NULL
,	NULL
DeVroede	NULL
,	NULL
M.	NULL
,	NULL
Loriaux	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Lipsett	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Primary	NULL
cortisol	NULL
resistance	NULL
in	NULL
man	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
69	NULL
:	NULL
1261-1269	NULL
,	NULL
1982	NULL
.	NULL

2216s	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1989	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

AAGR	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
Cancer	NULL
Research	NULL
The	NULL
Journal	NULL
of	NULL
Cancer	NULL
Research	NULL
(	NULL
1916-1930	NULL
)	NULL
|	NULL
The	NULL
American	NULL
Journal	NULL
of	NULL
Cancer	NULL
(	NULL
1931-1940	NULL
)	NULL
Properties	NULL
of	NULL
Glucocorticoid	NULL
Receptors	NULL
in	NULL
Epstein-Barr	NULL
Virus-transformed	NULL
Lymphocytes	NULL
from	NULL
Patients	NULL
with	NULL
Familial	NULL
Cortisol	NULL
Resistance	NULL
Sayomi	NULL
lida	NULL
,	NULL
Masahiro	NULL
Gomi	NULL
,	NULL
Kaname	NULL
Moriwaki	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Cancer	NULL
Res	NULL
1989	NULL
;	NULL
49:2214s-2216s	NULL
.	NULL

Updated	NULL
version	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/49/8_Supplement/2214s	NULL
E-mail	NULL
alerts	NULL
Reprints	NULL
and	NULL
Subscriptions	NULL
Permissions	NULL
Sign	NULL
up	NULL
to	NULL
receive	NULL
free	NULL
email-alerts	NULL
related	NULL
to	NULL
this	NULL
article	NULL
or	NULL
journal	NULL
.	NULL

To	NULL
order	NULL
reprints	NULL
of	NULL
this	NULL
article	NULL
or	NULL
to	NULL
subscribe	NULL
to	NULL
the	NULL
journal	NULL
,	NULL
contact	NULL
the	NULL
AACR	NULL
Publications	NULL
Department	NULL
at	NULL
pubs	NULL
@	NULL
aacr.org	NULL
.	NULL

To	NULL
request	NULL
permission	NULL
to	NULL
re-use	NULL
all	NULL
or	NULL
part	NULL
of	NULL
this	NULL
article	NULL
,	NULL
use	NULL
this	NULL
link	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/49/8_Supplement/2214s	NULL
.	NULL

Click	NULL
on	NULL
``	NULL
Request	NULL
Permissions	NULL
``	NULL
which	NULL
will	NULL
take	NULL
you	NULL
to	NULL
the	NULL
Copyright	NULL
Clearance	NULL
Center	NULL
's	NULL
(	NULL
CCC	NULL
)	NULL
Rightslink	NULL
site	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1989	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

